HVC
AZN icon

Healthcare Value Capital’s AstraZeneca AZN Stock Holding History

Healthcare Value Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-150,000
Closed -$10.3M – 32
2015
Q1 		$10.3M Buy
+150,000
New +$10.4M 11.19% 1
2014
Q4 		– Sell
-50,000
Closed -$3.57M – 28
2014
Q3 		$3.57M Buy
+50,000
New +$3.66M 3.45% 12
2013
Q3 		– Sell
-25,000
Closed -$1.18M – 52
2013
Q2 		$1.18M Buy
+25,000
New +$1.27M 0.86% 39

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Healthcare Value Capital's AZN Position: Q3 2021 in Review

Healthcare Value Capital held its AstraZeneca (AZN) position steady in Q3 2021 at 25,000 shares worth $3M. The position accounts for 5.93% of the portfolio, ranked #8.

Healthcare Value Capital first reported a position in AZN in Q2 2013 and has held it in 14 quarters since. The position peaked at $7.43M in Q2 2014. 906 funds tracked by Wall St. Rank hold AZN as of Q3 2021.

  • Healthcare Value Capital held 25,000 shares of AstraZeneca worth $3M as of Q3 2021.
  • Healthcare Value Capital left its AstraZeneca share count unchanged in Q3 2021.
  • AstraZeneca made up 5.93% of Healthcare Value Capital's portfolio in Q3 2021, its #8 holding.
  • Healthcare Value Capital first reported a position in AstraZeneca in Q2 2013 and has held it in 14 quarters since.
  • Healthcare Value Capital's AstraZeneca position peaked at $7.43M in Q2 2014.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2021.

Based on Healthcare Value Capital's 13F filing for Q3 2021, filed 15 Nov 2021.